296 related articles for article (PubMed ID: 19393835)
1. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
2. Recent Progress in DNA Damage Response-Targeting PROTAC Degraders.
Cheng B; Fei X; Ding Z; Peng X; Su Z; Pan W; Chen J
J Med Chem; 2024 May; 67(9):6906-6921. PubMed ID: 38663873
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic opportunities within the DNA damage response.
Pearl LH; Schierz AC; Ward SE; Al-Lazikani B; Pearl FM
Nat Rev Cancer; 2015 Mar; 15(3):166-80. PubMed ID: 25709118
[TBL] [Abstract][Full Text] [Related]
4. NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
Lawrence YR; Vikram B; Dignam JJ; Chakravarti A; Machtay M; Freidlin B; Takebe N; Curran WJ; Bentzen SM; Okunieff P; Coleman CN; Dicker AP
J Natl Cancer Inst; 2013 Jan; 105(1):11-24. PubMed ID: 23231975
[TBL] [Abstract][Full Text] [Related]
5. Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer.
Ng YB; Akincilar SC
Curr Opin Pharmacol; 2024 Jun; 76():102460. PubMed ID: 38776747
[TBL] [Abstract][Full Text] [Related]
6. Targeting protein-protein interactions in the DNA damage response pathways for cancer chemotherapy.
McPherson KS; Korzhnev DM
RSC Chem Biol; 2021 Aug; 2(4):1167-1195. PubMed ID: 34458830
[TBL] [Abstract][Full Text] [Related]
7. Advances in DNA damage response inhibitors in colorectal cancer therapy.
Yu Y; Jia H; Zhang T; Zhang W
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):15-22. PubMed ID: 38115743
[TBL] [Abstract][Full Text] [Related]
8. The DNA Damage Response and Inflammation in Cancer.
Klapp V; Álvarez-Abril B; Leuzzi G; Kroemer G; Ciccia A; Galluzzi L
Cancer Discov; 2023 Jul; 13(7):1521-1545. PubMed ID: 37026695
[TBL] [Abstract][Full Text] [Related]
9. Targeting DNA repair pathway in cancer: Mechanisms and clinical application.
Wang M; Chen S; Ao D
MedComm (2020); 2021 Dec; 2(4):654-691. PubMed ID: 34977872
[TBL] [Abstract][Full Text] [Related]
10. Alerting the immune system to DNA damage: micronuclei as mediators.
MacDonald KM; Benguerfi S; Harding SM
Essays Biochem; 2020 Oct; 64(5):753-764. PubMed ID: 32844183
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy.
Zhao SJ; Prior D; Heske CM; Vasquez JC
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730598
[TBL] [Abstract][Full Text] [Related]
12. Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies.
Restifo D; McDermott JR; Cvetkovic D; Dos Santos T; Ogier C; Surumbayeva A; Handorf EA; Schimke C; Ma C; Cai KQ; Olszanski AJ; Kathad U; Bhatia K; Sharma P; Kulkarni A; Astsaturov I
Mol Cancer Ther; 2023 Oct; 22(10):1182-1190. PubMed ID: 37552607
[TBL] [Abstract][Full Text] [Related]
13. The emerging relationship between metabolism and DNA repair.
Cucchi D; Gibson A; Martin SA
Cell Cycle; 2021 May; 20(10):943-959. PubMed ID: 33874857
[TBL] [Abstract][Full Text] [Related]
14. DNA repair, genome stability and cancer: a historical perspective.
Jeggo PA; Pearl LH; Carr AM
Nat Rev Cancer; 2016 Jan; 16(1):35-42. PubMed ID: 26667849
[TBL] [Abstract][Full Text] [Related]
15. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.
Huang R; Zhou PK
Signal Transduct Target Ther; 2021 Jul; 6(1):254. PubMed ID: 34238917
[TBL] [Abstract][Full Text] [Related]
16. Translation of DNA Damage Response Inhibitors as Chemoradiation Sensitizers From the Laboratory to the Clinic.
Parsels LA; Zhang Q; Karnak D; Parsels JD; Lam K; Willers H; Green MD; Rehemtulla A; Lawrence TS; Morgan MA
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):e38-e53. PubMed ID: 34348175
[TBL] [Abstract][Full Text] [Related]
17. DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage.
Reuvers TGA; Kanaar R; Nonnekens J
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731592
[TBL] [Abstract][Full Text] [Related]
18. Bridging Plant and Human Radiation Response and DNA Repair through an In Silico Approach.
Nikitaki Z; Pavlopoulou A; Holá M; Donà M; Michalopoulos I; Balestrazzi A; Angelis KJ; Georgakilas AG
Cancers (Basel); 2017 Jun; 9(6):. PubMed ID: 28587301
[TBL] [Abstract][Full Text] [Related]
19. External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.
Pokrovska TD; Jacobus EJ; Puliyadi R; Prevo R; Frost S; Dyer A; Baugh R; Rodriguez-Berriguete G; Fisher K; Granata G; Herbert K; Taverner WK; Champion BR; Higgins GS; Seymour LW; Lei-Rossmann J
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224979
[TBL] [Abstract][Full Text] [Related]
20. DNA folds threaten genetic stability and can be leveraged for chemotherapy.
Zell J; Rota Sperti F; Britton S; Monchaud D
RSC Chem Biol; 2021 Feb; 2(1):47-76. PubMed ID: 35340894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
